Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiming Shi

Showing results (101-110 of 112) with videos related to

Pageof 12
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 8, 2026
Shexiang Baoxin pill in patients with stable coronary artery disease and reduced eGFR: Subgroup analysis of phase IV randomized trialJingmin Zhou, Yanqiu Chen, Haiming Shi, et al.
Food Research International (Ottawa, Ont.)|August 9, 2017
Profiling hydroxycinnamic acid glycosides, iridoid glycosides, and phenylethanoid glycosides in baobab fruit pulp (Adansonia digitata)Xing-Nuo Li, Jianghao Sun, Haiming Shi, et al.
The American Journal of Cardiology|February 21, 2017
Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial FibrillationZhiyong Qi, Hua Chen, Zhichao Wen, et al.
Journal of Translational Medicine|May 24, 2024
IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy miceQingyu Huang, Tongqing Chen, Jian Li, et al.
Clinical Cardiology|February 4, 2022
Cilostazol combined with P2Y<sub>12</sub> receptor inhibitors: A substitute antiplatelet regimen for aspirin-intolerant patients undergoing percutaneous coronary stent implantationYikai Zhao, Peng Zhou, Wen Gao, et al.
British Journal of Hospital Medicine (London, England : 2005)|July 7, 2026
The Association Between Glycemic Disorders and Acute Coronary Syndrome: Plaque Vulnerability in Perimenopausal and Post-Menopausal Women With DiabetesRongchen Liu, Chen Sheng, Yujie Song, et al.
Journal of Ethnopharmacology|January 10, 2025
Efficacy and safety of Shexiang Baoxin Pill (MUSKARDIA) in patients with stable coronary artery disease across different weight subgroupsJingmin Zhou, Haiming Shi, Yulan Zhao, et al.
Journal of Thrombosis and Thrombolysis|April 15, 2020
A stricter control of low-density lipoprotein is necessary for thrombosis reduction in "lower thrombosis risk" patients with atrial fibrillation: a multicenter retrospective cohort studyWeizhuo Liu, Nanqing Xiong, Kun Xie, et al.
Biochemical Pharmacology|November 8, 2021
NOD2-mediated P2Y<sub>12</sub> upregulation increases platelet activation and thrombosis in sepsisHaoxuan Zhong, Maieryemu Waresi, Wei Zhang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 15, 2015
[Efficacy comparison between 5 mg perindopril arginine salt and 4 mg perindopril tert-butylamine salt for patients with mild to moderate essential hypertension]Litong Qi, Shuiping Zhao, Hui Li, et al.
Pageof 12

Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 8, 2026
Shexiang Baoxin pill in patients with stable coronary artery disease and reduced eGFR: Subgroup analysis of phase IV randomized trialJingmin Zhou, Yanqiu Chen, Haiming Shi, et al.
Food Research International (Ottawa, Ont.)|August 9, 2017
Profiling hydroxycinnamic acid glycosides, iridoid glycosides, and phenylethanoid glycosides in baobab fruit pulp (Adansonia digitata)Xing-Nuo Li, Jianghao Sun, Haiming Shi, et al.
The American Journal of Cardiology|February 21, 2017
Relation of Low-Density Lipoprotein Cholesterol to Ischemic Stroke in Patients With Nonvalvular Atrial FibrillationZhiyong Qi, Hua Chen, Zhichao Wen, et al.
Journal of Translational Medicine|May 24, 2024
IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy miceQingyu Huang, Tongqing Chen, Jian Li, et al.
Clinical Cardiology|February 4, 2022
Cilostazol combined with P2Y<sub>12</sub> receptor inhibitors: A substitute antiplatelet regimen for aspirin-intolerant patients undergoing percutaneous coronary stent implantationYikai Zhao, Peng Zhou, Wen Gao, et al.
British Journal of Hospital Medicine (London, England : 2005)|July 7, 2026
The Association Between Glycemic Disorders and Acute Coronary Syndrome: Plaque Vulnerability in Perimenopausal and Post-Menopausal Women With DiabetesRongchen Liu, Chen Sheng, Yujie Song, et al.
Journal of Ethnopharmacology|January 10, 2025
Efficacy and safety of Shexiang Baoxin Pill (MUSKARDIA) in patients with stable coronary artery disease across different weight subgroupsJingmin Zhou, Haiming Shi, Yulan Zhao, et al.
Journal of Thrombosis and Thrombolysis|April 15, 2020
A stricter control of low-density lipoprotein is necessary for thrombosis reduction in "lower thrombosis risk" patients with atrial fibrillation: a multicenter retrospective cohort studyWeizhuo Liu, Nanqing Xiong, Kun Xie, et al.
Biochemical Pharmacology|November 8, 2021
NOD2-mediated P2Y<sub>12</sub> upregulation increases platelet activation and thrombosis in sepsisHaoxuan Zhong, Maieryemu Waresi, Wei Zhang, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|December 15, 2015
[Efficacy comparison between 5 mg perindopril arginine salt and 4 mg perindopril tert-butylamine salt for patients with mild to moderate essential hypertension]Litong Qi, Shuiping Zhao, Hui Li, et al.
Pageof 12